Literature DB >> 185113

The metabolic fate of plasma lipoproteins in normal subjects and in patients with insulin resistance and endogenous hypertriglyceridaemia.

A H Kissebah, S Alfarsi, P W Adams, V Wynn.   

Abstract

Using I131 VLDL selectively labelled in the B-apoprotein and I125 LDL injected simultaneously into the patient we have derived some quantitative measures of VLDL and LDL metabolism in man. The effects of insulin resistance, associated with idiopathic hypertriglyceridaemia, adult onset diabetes and diabetic lipodystrophy on the metabolic behaviour of these molecules were also assessed. In the normal subjects 72-83% of the total daily plasma VLDL B-apoprotein flux was metabolised via a pathway which involved its ultimate conversion to plasma LDL, while 21-28% was degraded without such conversion. The amount of B-apoprotein metabolised by either of these routes was proportionate to the flux rate and the two pathways accounted for the total VLDL B-apoprotein removed from the plasma. In patients with idiopathic hypertriglyceridaemia and in the adult onset diabetics the total plasma VLDL B-apoprotein flux was higher than normal, indicating increased production of this apoprotein. On the other hand, the flux rate of plasma VLDL B-apoprotein in the patients with diabetic lipodystrophy was normal, suggesting that the increase in the circulating mass of these molecules was due to impaired clearance. In all the patients, however, the fractions of the total flux either converted to LDL or degraded were lower than normal, suggesting that insulin resistance limited the removal of this apoprotein by these pathways. The results also indicate that a fraction of the total VLDL removed from the plasma has been retained in an extravascular compartment, possibly representing VLDL molecules trapped in the vascular structures. In the control and the insulin resistant subjects the quantity of LDL apoprotein catabolised per day agreed closely with the amount derived from VLDL B-apoprotein conversion, suggesting that VLDL-B-apoprotein serves as the main source of LDL apoprotein. In patients with idiopathic hypertriglyceridaemia and in adult onset diabetics the absolute turnover rate of plasma LDL apoprotein was higher than normal, while in the lipodystrophic patients it was reduced. It is suggested that the increase in LDL turnover seen in the former groups could be an additive factor in the deposition of lipid rich material in arterial walls.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 185113     DOI: 10.1007/bf01219515

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  23 in total

1.  PLASMA-INSULIN CONCENTRATIONS AFTER MYOCARDIAL INFRACTION.

Authors:  N PETERS; C N HALES
Journal:  Lancet       Date:  1965-05-29       Impact factor: 79.321

2.  The design and analysis of isotope experiments.

Authors:  D B ZILVERSMIT
Journal:  Am J Med       Date:  1960-11       Impact factor: 4.965

3.  The theory of tracer experiments with 131I-labelled plasma proteins.

Authors:  C M MATTHEWS
Journal:  Phys Med Biol       Date:  1957-07       Impact factor: 3.609

4.  Lipoprotein uptake and metabolism by rat aortic smooth muscle cells in tissue culture.

Authors:  E L Bierman; O Stein; Y Stein
Journal:  Circ Res       Date:  1974-07       Impact factor: 17.367

5.  A rapid electrophoretic technique for identification of subunit species of apoproteins in serum lipoproteins.

Authors:  J P Kane
Journal:  Anal Biochem       Date:  1973-06       Impact factor: 3.365

6.  The metabolism of very low density lipoprotein proteins. II. Studies on the transfer of apoproteins between plasma lipoproteins.

Authors:  S Eisenberg; D W Bilheimer; R I Levy
Journal:  Biochim Biophys Acta       Date:  1972-09-07

7.  Reappraisal of the role of insulin in hypertriglyceridemia.

Authors:  J M Olefsky; J W Farquhar; G M Reaven
Journal:  Am J Med       Date:  1974-10       Impact factor: 4.965

8.  Serum-insulin in essential hypertension and in peripheral vascular disease.

Authors:  T A Welborn; A Breckenridge; A H Rubinstein; C T Dollery; T R Fraser
Journal:  Lancet       Date:  1966-06-18       Impact factor: 79.321

9.  Studies of the proteins in human plasma very low density lipoproteins.

Authors:  W V Brown; R I Levy; D S Fredrickson
Journal:  J Biol Chem       Date:  1969-10-25       Impact factor: 5.157

10.  Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man.

Authors:  A H Kissebah; S Alfarsi; P W Adams; V Wynn
Journal:  Diabetologia       Date:  1976-12       Impact factor: 10.122

View more
  4 in total

Review 1.  Studying apolipoprotein turnover with stable isotope tracers: correct analysis is by modeling enrichments.

Authors:  Rajasekhar Ramakrishnan
Journal:  J Lipid Res       Date:  2006-09-01       Impact factor: 5.922

2.  Metabolic effects of obesity: A review.

Authors:  Parul Singla; Animesh Bardoloi; Anuj A Parkash
Journal:  World J Diabetes       Date:  2010-07-15

3.  Lipokinetic studies with gemfibrozil (CI-719).

Authors:  A H Kissebah; P A Adams; V Wynn
Journal:  Proc R Soc Med       Date:  1976

4.  Effect of Leptin Replacement on PCSK9 in ob/ob Mice and Female Lipodystrophic Patients.

Authors:  Amy E Levenson; Mary E Haas; Ji Miao; Rebecca J Brown; Sarah D de Ferranti; Ranganath Muniyappa; Sudha B Biddinger
Journal:  Endocrinology       Date:  2016-01-29       Impact factor: 4.736

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.